The platelet volume of the infants were found low in the preoperative examinations and spontaneous recovery of ROP was seen after the regulation of thrombocytopenia.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:It was declared that platelets had a role on the prevention of VEGF related neovascularization and thrombocytopenia had related with the increased risk of severe retinopathy of prematurity (ROP).1 Data from 4 eyes of 2 premature infants with Type 1 ROP were presented in this article.
📊
Key Findings & Data:It was declared that platelets had a role on the prevention of VEGF related neovascularization and thrombocytopenia had related with the increased risk of severe retinopathy of prematurity (ROP).1 Data from 4 eyes of 2 premature infants with Type 1 ROP were presented in this article.
💡
Conclusion & Impact:The platelet volume of the infants were found low in the preoperative examinations and spontaneous recovery of ROP was seen after the regulation of thrombocytopenia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
It was declared that platelets had a role on the prevention of VEGF related neovascularization and thrombocytopenia had related with the increased risk of severe retinopathy of prematurity (ROP).1 Data from 4 eyes of 2 premature infants with Type 1 ROP were presented in this article. The platelet volume of the infants were found low in the preoperative examinations and spontaneous recovery of ROP was seen after the regulation of thrombocytopenia.
Özet
Trombositlerin, artmış vasküler endotelyal büyüme faktörüne (VEGF) bağlı neovaskülarizasyon gelişme riskini azaltmada rol oynadığı ve trombositopenisi olan prematüre bebeklerde tedavi gerektiren prematüre retinopatisi (PR) oluşma riskinin arttığı daha önce bildirilmiştir.1 Bu yazıda, PR takipleri esnasında Tip 1 PR tanısı ile laser fotokoagülasyon tedavisi kararı alınan ve preoperatif saptanan trombosit düşüklüğünün düzeltilmesi sonrası spontan iyileşme gösteren 2 prematüre bebeğin 4 gözüne ait veriler sunulmuştur.
🔖
Cite This Article
TUNAY, Z. Ö., ÖZDEMİR, Ö., ERGİNTÜRK, D. A., SARI, F. N. (2016). Cases with Type 1 Retinopathy of Prematurity That were Improved with the Regulation of Thrombocytopenia. Retina-Vitreus, Cilt: 24 - Sayı: 4, 337–339. https://ajindex.com/articles/307993
References (7)
Jensen AK, Ying G, Huang J, et al. Thrombocytopenia and retinopathy of prematurity. J AAPOS.2011;15:3-4.
Sarikabadayi YU, Aydemir O, Ozen ZT, et al. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors. Ophthalmic Epidemiol. 2011;18:269-74.
Smith LE, Hard AL, Hellström A. The biology of retinopathy of prema- turity: how knowledge of pathogenesis guides treatment. Clin Perinatol. 2013;40:201-14.
Cavallaro G, Filippi L, Bagnoli P, et al. The pathophysiology of retino- pathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014;92:2-20.
Vinekar A, Hegde K, Gilbert C, et al. Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity? Reti- na. 2010;30:20-3. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol. 2003;121:1684-96.
Italiano JE, Richardson JL, Patel-Hett S, et al. Angiogenesis is regula- ted by a novel mechanism:pro- and antiangiogenic proteins are orga- nized into separate platelet alpha granules and differentially released. Blood. 2008;111:1227-33. Cekmez F,Tanju IA, Canpolat FE, et al. Mean platelet volume in very preterm infants:a predictor of morbidities?. European Review for Me- dical and Pharmacological Sciences. 2013;17:134-7.
Soh Y, Fujino T, Hatsukawa Y. Progression and timing of treatment of zone I retinopathy of prematurity. Am J Ophthalmol. 2008;146:369-74.